Table 2.
Univariate Cox regression analysis of factors related to persistent AF recurrence
| Characteristic | HR (95%CI) | p value |
|---|---|---|
| Age | 1.006 (0.976–1.037) | 0.695 |
| Gender (female vs. male) | 2.099 (1.087–4.053) | 0.027 |
| BMI | 1.003 (0.926–1.087) | 0.936 |
| AF duration | 1.006 (0.999–1.013) | 0.089 |
| Diagnosis and treatment | ||
| CAD | 0.719 (0.22–2.351) | 0.585 |
| HTN | 1.2 (0.608–2.37) | 0.599 |
| DM | 0.689 (0.243–1.952) | 0.483 |
| stroke | 1.37 (0.53–3.539) | 0.516 |
| Statins | 0.9 (0.41–1.975) | 0.792 |
| ACEI/ARB | 1.325 (0.623–2.82) | 0.465 |
| CCB | 1.096 (0.499–2.407) | 0.819 |
| Beta-block | 0.939 (0.41–2.15) | 0.882 |
| EHRA score | ||
| 1 | 1 (ref) | |
| 2 | 1.477 (0.574–3.801) | 0.419 |
| 3 | 1.184 (0.448–3.134) | 0.733 |
| CHA2DS2-VASc score ≥ 2 | 1.117 (0.58–2.153) | 0.741 |
| HAS-BLED score ≥ 3 | 0.599 (0.082–4.381) | 0.614 |
| Non-PV ablation | 1.003 (0.516–1.947) | 0.994 |
| LAd, mm (≥ 40 vs. < 40) | 1.966 (0.982–3.937) | 0.056 |
| LVEF, % (≥ 50% vs. < 50%) | 1.126 (0.154–8.237) | 0.907 |